FBT is one of a handful of biotech ETFs available, offering exposure to a corner of the market that can perform well during periods of consolidation and is capable of big jumps in the event of major drug approvals. FBT focuses on a narrow sector of the health care market segment, and as such is probably too precise for most investors seeking to construct a long-term portfolio. But this ETF can be useful for those seeking to fine tune exposure or for those bullish on the sector over the long run. FBT focuses primarily on U.S. stocks, and consists primarily of mid cap and small cap securities. FBT’s portfolio is somewhat limited, though the equal-weighted methodology of the underlying index ensures that assets are balanced across all components. That feature can be particularly important in the biotech space, where specific companies are capable of turning in big gains over short periods of time. PBE and IBB are other ETF options for biotech exposure; those considering this sector should take a close look at depth of exposure and weighing methodology, as these factors can have a major impact on the risk and return profiles achieved.
| Segment | Equity: U.S. Biotechnology |
| Category | Sector |
| Focus | Health Care |
| Niche | Biotechnology |
| Strategy | Equal |
| Weighting Scheme | Equal |
This section compares how balanced and deep this ETF is relative to its peers.
| FBT | ETF Database Category Average | FactSet Segment Average | |
|---|---|---|---|
| Number of Holdings | 31 | 89 | 107 |
| % of Assets in Top 10 | 38.03% | 43.47% | 34.71% |
| % of Assets in Top 15 | 54.69% | 56.05% | 45.81% |
| % of Assets in Top 50 | 99.98% | 90.56% | 85.04% |
| FBT | ETF Database Category Average | FactSet Segment Average | |
|---|---|---|---|
| Large (>12.9B) | 53.91% | 48.58% | 30.03% |
| Mid (>2.7B) | 39.04% | 28.01% | 38.56% |
| Small (>600M) | 7.01% | 17.75% | 27.56% |
| Micro (<600M) | 0.00% | 5.26% | 3.41% |
This section compares the P/E ratio of this ETF to its peers.
This section compares the dividend yield of this ETF to its peers.
| FBT | ETF Database Category Average | FactSet Segment Average | |
|---|---|---|---|
| Dividend | $ 2.21 | $ 0.29 | $ 0.40 |
| Dividend Date | 2021-12-30 | N/A | N/A |
| Annual Dividend Rate | N/A | $ 0.44 | $ 0.06 |
| Annual Dividend Yield | N/A | 0.48% | 0.04% |
View charts featuring FBT price and volume data.
View charts featuring ETF fund flow data.
5 Day Net Flows: 0 1 Month Net Flows: 0 3 Month Net Flows: -15.05 M 6 Month Net Flows: -7.58 M 1 Year Net Flows: -9.73 M 3 Year Net Flows: -496.09 M 5 Year Net Flows: 45.91 M 10 Year Net Flows: 809.46 MView charts that break down the influence that fund flows and price had on overall assets.
5 Day Net AUM Change: 43.84 MThe adjacent table gives investors an individual Realtime Rating for FBT on several different metrics, including liquidity, expenses, performance, volatility, dividend, concentration of holdings in addition to an overall rating. The "A+ Metric Rated ETF" field, available to ETF Database Pro members, shows the ETF in the Health & Biotech Equities with the highest Metric Realtime Rating for each individual field. To view all of this data, sign up for a free 14-day trial for ETF Database Pro. To view information on how the ETF Database Realtime Ratings work, click here.
This section compares the cost efficiency of this ETF to its peers.
| Max ST Capital Gains Rate | 39.60% |
| Max LT Capital Gains Rate | 20.00% |
| Tax On Distributions | Qualified dividends |
| Distributes K1 | No |
This section shows how this ETF has performed relative to its peers. Returns over 1 year are annualized.
| FBT |
ETF Database
Category Average |
Factset Segment
Average |
|
|---|---|---|---|
| 1 Month Return | 1.63% | -0.94% | 1.08% |
| 3 Month Return | 2.85% | 2.65% | 5.44% |
| YTD Return | 2.36% | 1.26% | 4.16% |
| 1 Year Return | 15.55% | 2.32% | 19.01% |
| 3 Year Return | -0.69% | 0.48% | -0.57% |
| 5 Year Return | 2.44% | 2.62% | 1.61% |
The following charts reflect the geographic spread of FBT's underlying holdings.
| Region | Percentage |
|---|---|
| North, Central and South America | 99.93% |
| Other | 0.05% |
| Country | Percentage |
|---|---|
| United States | 82.84% |
| Spain | 4.0% |
| Ireland | 3.53% |
| Netherlands | 3.34% |
| Denmark | 3.16% |
| Germany | 3.06% |
| Other | 0.05% |
The following charts reflect the allocation of FBT's underlying holdings.
| Sector | Percentage |
|---|---|
| Health Technology | 93.09% |
| Health Services | 3.45% |
| Commercial Services | 3.39% |
| CASH | 0.05% |
| Market Cap | Percentage |
|---|---|
| Large | 53.91% |
| Mid | 39.04% |
| Small | 7.01% |
| Micro | 0.0% |
| Region | Percentage |
|---|
| Asset | Percentage |
|---|---|
| Share/Common/Ordinary | 89.71% |
| American Depositary Receipt | 10.22% |
| CASH | 0.05% |
| Sector | Percentage |
|---|---|
| Health Technology | 93.09% |
| Health Services | 3.45% |
| Commercial Services | 3.39% |
| CASH | 0.05% |
This section shows how the volatility of this ETF compares to the peer group ETF Database Category.
| 5 Day Volatility | 74.07% |
| 20 Day Volatility | 15.85% |
| 50 Day Volatility | 16.11% |
| 200 Day Volatility | 16.63% |
| Beta | 0.79 |
| Standard Deviation | 9.70% |
ETF Database's Financial Advisor Reports are designed as an easy handout for clients to explain the key information on a fund. Includes new analyst insights and classification data.
Fact sheets are issued by the ETF provider and framed by ETF Database. Information contained within the fact sheet is not guaranteed to be timely or accurate.
VettaFi writer Elle Caruso recently sat down with Ryan Issakainen, ETF strategist at First Trust,...
Here is a look at the 25 best and 25 worst ETFs from the past trading month. Traders can use this...
Here is a look at the 25 best and 25 worst ETFs from the past week. Traders can use this list to...
ETF Trends and ETF Database , the preeminent digital platforms for ETF news, research, tools, video, webcasts, native content channels, and more. The ETF Trends and ETF Database brands have been trusted amongst advisors, institutional investors, and individual investors for a combined 25 years. The firms are uniquely positioned to aid advisor’s education, adoption, and usage of ETFs, as well as the asset management community’s transition from traditionally analog to digital interactions with the advisor community.
Our team at ETF Database is committed to making our website the premier source of information on ETF investing with the world’s highest quality ETF tools, content, and resources.
ETF Database analysts have a combined 50 years in the ETF and Financial markets, covering every asset class and investment style. The team monitors new filings, new launches and new issuers to make sure we place each new ETF in the appropriate context so Financial Advisors can construct high quality portfolios.
Copyright © 2023 FactSet Research Systems Inc. All rights reserved.
A long-running debate in asset allocation circles is how much of a portfolio an investor should...
In a digital age where information moves in milliseconds and millions of participants can transact...